Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ -36.03EBITDA per Share
VS
Market
Sector
Industry
History
$ 3.96Close
$ 3.67 - $ 55.05 52-Week Range
Ticker Information
Ticker
SLRXCompany Name
SALARIUS PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQSALARIUS PHARMACEUTICALS INC - EBITDA per Share Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
SLRX - EBITDAPS Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA per Share | Share Factor | Weighted Average Shares |
|---|---|---|---|---|
| 6/30/2025 | $ -5.1M | $ -36.03 | 1 | 141.53K |
| 3/31/2025 | $ -5.57M | $ -50.17 | 1 | 110.93K |
| 12/31/2024 | $ -5.57M | $ -86.85 | 1 | 64.15K |
| 9/30/2024 | $ -4.99M | $ -58.38 | 1 | 85.46K |
| 6/30/2024 | $ -6.46M | $ -161.27 | 1 | 40.03K |
| 3/31/2024 | $ -8.91M | $ -254.83 | 1 | 34.95K |
| 12/31/2023 | $ -12.53M | $ -460.67 | 1 | 27.2K |
| 9/30/2023 | $ -17.91M | $ -572.42 | 1 | 31.28K |
| 6/30/2023 | $ -29.96M | $ -1.33K | 1 | 22.58K |
| 3/31/2023 | $ -30.83M | $ -1.55K | 1 | 19.93K |
Key Performance Insights, Last 5 Years
- SALARIUS PHARMACEUTICALS INC's latest trailing twelve months (TTM) EBITDAPS stands at $ -1.24K.
- Over the past 5 years, SALARIUS PHARMACEUTICALS INC's average EBITDAPS has been $ -779.72.
- The median EBITDAPS for SALARIUS PHARMACEUTICALS INC during this period was $ -696.75
- SALARIUS PHARMACEUTICALS INC reached its highest EBITDAPS over the past 5 years at $ -36.03.
- The lowest EBITDAPS recorded by SALARIUS PHARMACEUTICALS INC in the same timeframe $ -1.78K
Similar metrics to Shares WA:
- EBIT per Share - [Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Book Value per Share - [Calculation] The amount of equity attributed to each share, calculated as [Equity] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Sales per Share - [Calculation] The amount of revenue attributed to each share, calculated as [Revenue] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Free Cash Flow per Share - [Calculation] The amount of Free Cash Flow attributed to each share, calculated as [FCF] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of EBITDA per Share
[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for SALARIUS PHARMACEUTICALS INC is calculated as follows: EBITDA [ $ -7.43M ] / (Shares WA [ 5.99K ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -1.24K ] SLRX - EBITDA per Share, Last 5 years
$ -1.78K
Minimum
Dec 31, 2022
$ -36.03
Maximum
Jun 30, 2025
$ -779.72
Average
$ -696.75
Median
EBITDAPS Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.03 with a standard deviation of $ 4.28.
The following table provides additional summary stats:
EBITDAPS in the Market:
| filtered constituents | 3.78K |
|---|---|
| min | $ -11.29 |
| max | $ 14.03 |
| average | $ 2.03 |
| median | $ 1 |
| std | $ 4.28 |